Insufficient scRNA-seq data for expression of CIDEA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 88% | 5841.87 | 405 / 459 | 47% | 5.33 | 520 / 1118 |
adipose | 99% | 7609.31 | 1196 / 1204 | 0% | 0 | 0 / 0 |
skin | 63% | 667.67 | 1137 / 1809 | 18% | 1.72 | 83 / 472 |
bladder | 19% | 48.62 | 4 / 21 | 23% | 1.29 | 117 / 504 |
brain | 24% | 69.63 | 642 / 2642 | 14% | 0.48 | 102 / 705 |
esophagus | 20% | 102.63 | 283 / 1445 | 19% | 0.64 | 34 / 183 |
adrenal gland | 8% | 42.82 | 21 / 258 | 13% | 0.88 | 31 / 230 |
pancreas | 1% | 3.06 | 3 / 328 | 19% | 1.56 | 34 / 178 |
eye | 0% | 0 | 0 / 0 | 19% | 1.21 | 15 / 80 |
blood vessel | 13% | 188.75 | 178 / 1335 | 0% | 0 | 0 / 0 |
intestine | 8% | 54.24 | 79 / 966 | 4% | 0.29 | 23 / 527 |
stomach | 3% | 42.85 | 11 / 359 | 9% | 0.47 | 25 / 286 |
ovary | 0% | 0 | 0 / 180 | 11% | 0.48 | 46 / 430 |
heart | 9% | 37.63 | 81 / 861 | 0% | 0 | 0 / 0 |
uterus | 1% | 13.68 | 2 / 170 | 8% | 1.08 | 36 / 459 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.29 | 4 / 45 |
liver | 1% | 1.47 | 2 / 226 | 8% | 1.27 | 32 / 406 |
thymus | 4% | 17.34 | 24 / 653 | 3% | 0.14 | 20 / 605 |
muscle | 6% | 21.40 | 45 / 803 | 0% | 0 | 0 / 0 |
lung | 0% | 0 | 0 / 578 | 5% | 0.21 | 53 / 1155 |
kidney | 1% | 14.24 | 1 / 89 | 2% | 0.11 | 21 / 901 |
prostate | 2% | 7.73 | 4 / 245 | 1% | 0.04 | 4 / 502 |
peripheral blood | 0% | 1.61 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010890 | Biological process | positive regulation of sequestering of triglyceride |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_1900118 | Biological process | negative regulation of execution phase of apoptosis |
GO_0035634 | Biological process | response to stilbenoid |
GO_0120009 | Biological process | intermembrane lipid transfer |
GO_0070417 | Biological process | cellular response to cold |
GO_0160077 | Biological process | lipid droplet fusion |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0019915 | Biological process | lipid storage |
GO_0001818 | Biological process | negative regulation of cytokine production |
GO_0050995 | Biological process | negative regulation of lipid catabolic process |
GO_0006915 | Biological process | apoptotic process |
GO_0001659 | Biological process | temperature homeostasis |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0006629 | Biological process | lipid metabolic process |
GO_1902510 | Biological process | regulation of apoptotic DNA fragmentation |
GO_0120163 | Biological process | negative regulation of cold-induced thermogenesis |
GO_0005811 | Cellular component | lipid droplet |
GO_0005739 | Cellular component | mitochondrion |
GO_0005740 | Cellular component | mitochondrial envelope |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0120013 | Molecular function | lipid transfer activity |
GO_0070300 | Molecular function | phosphatidic acid binding |
Gene name | CIDEA |
Protein name | Cell death activator CIDE-A variant 2 (Cell death-inducing DFFA-like effector a) Cell death inducing DFFA like effector a Lipid transferase CIDEA (Cell death activator CIDE-A) (Cell death-inducing DFFA-like effector A) |
Synonyms | |
Description | FUNCTION: Lipid transferase that promotes unilocular lipid droplet formation by mediating lipid droplet fusion . Lipid droplet fusion promotes their enlargement, restricting lipolysis and favoring lipid storage . Localizes on the lipid droplet surface, at focal contact sites between lipid droplets, and mediates atypical lipid droplet fusion by promoting directional net neutral lipid transfer from the smaller to larger lipid droplets (By similarity). The transfer direction may be driven by the internal pressure difference between the contacting lipid droplet pair and occurs at a lower rate than that promoted by CIDEC (By similarity). May also act as a CEBPB coactivator in epithelial cells to control the expression of a subset of CEBPB downstream target genes, including ID2, IGF1, PRLR, SOCS1, SOCS3, XDH, but not casein (By similarity). By interacting with CEBPB, strengthens the association of CEBPB with the XDH promoter, increases histone acetylation and dissociates HDAC1 from the promoter (By similarity). When overexpressed, induces apoptosis; the physiological significance of its role in apoptosis is unclear (By similarity). . |
Accessions | O60543 ENST00000522713.5 E5RJ03 ENST00000320477.10 Q8N5P9 |